摘要
目的:观察拉西地平对糖尿病并发高血压和单纯高血压的治疗效果。方法:单纯高血压和糖尿病并发高血压各25例,服安慰剂 2 wk后服用拉西地平2 mg,如血压未降至正常,则渐增到4,6 mg或 8 mg,po, qm, pc,共 6 wk。结果: 2组治疗 2wk后收缩压分别下降达(3.4±0.6)kPa或(3.5±0.6)kPa,(P<0.01);舒张压分别下降达(2.0±0. 3) kPa或(2. 2± 0. 4) kPa( P< 0. 05)。治疗 4 wk及6wk,均显示收缩压进一步下降;舒张压均维持原疗效;治疗6wk期间对心率、血糖、血脂均无显著影响。结论:拉西地平治疗单纯性或糖尿病并发高血压均有较好疗效。
AIM: AIM: To study lacidipine treatment on diabetic and nondiabetic hypertensive patients. METHODS: Hypertensive patients with (n = 25) and without (n = 25 ) non-insulin- depen-dent diabetes mullitus were given placebo for 2 wk and then lacidipine 2 mg, po, after breakfast for 6 wk. The dosage was increased to 4, 6, or 8 mg if blood pressure was not controlled in normal range. RESULTS: The present study indicates that lacidipine significantly reduced blood pressure after 2 wk (P <0. 01, or P<0. 05) as the treatment time goes on (at 4 wk, 6 wk), the SBP was further depressed, and the DBP effect can be maintained. Lacidipine can' t interference of blood lipid and blood glucose. CONCLUSION: Lacidipine is a' good antihypertensive drug in hypertensive patients with and without NIDDM.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2000年第2期121-123,共3页
Chinese Journal of New Drugs and Clinical Remedies
关键词
拉西地平
高血压
糖尿病
并发症
药物疗法
lacidipine
hypertension
non- in-sulin-dependent diabetes mellitus
calcium channel blockers